Fernando J. Aranda
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Engineering interleukin-10 for therapeutic applications.
Journal: International review of cell and molecular biology
Published: May 20, 2026
Trispecific engager overcomes tumoural immunosuppressive environment.
Journal: Nature biomedical engineering
Published: December 10, 2025
Dichotomy of IL-27 in tumor immunity.
Journal: International review of cell and molecular biology
Published: July 23, 2025
Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA.
Journal: Theranostics
Published: July 21, 2025
The long-lasting expression of recombinant artLCMV following intraperitoneal administration exerts potent antitumor effects on tumor models of peritoneal carcinomatosis.
Journal: Oncoimmunology
Published: June 24, 2025
Multicolor Flow Cytometry for Immune Characterization of Omental Metastasis in Peritoneal Carcinomatosis Mice Models.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 22, 2025
Latest insights into oncolytic viro-immunotherapy with vesicular stomatitis virus.
Journal: Seminars in immunology
Published: April 11, 2025
Immunocytokines and cytokine neutralization for cancer immunotherapy.
Journal: Trends in cancer
Published: March 12, 2025
The OT-II model reveals dual in vitro and in vivo immunomodulatory properties of CD6 in T cell activation.
Journal: Frontiers in immunology
Published: February 05, 2025
Animal models of disease: Achievements and challenges.
Journal: Methods in cell biology
Published: January 25, 2025
Intratumoral administration of Hibiscus sabdariffa-derived anthocyanins exerts potent antitumor effects in murine cancer models.
Journal: Frontiers in immunology
Published: December 22, 2024
Last Updated: 09/26/2026